| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription factor binding | RBBP8 SALL4 DAXX PSMD9 HNF4A TFDP1 NCOR1 GTF2H1 SALL1 HEY1 ATXN3 SMARCE1 NR3C2 MAP3K7 NFAT5 MED12 | 9.20e-06 | 753 | 118 | 16 | GO:0008134 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZBTB4 DACH1 POU2F1 SALL4 HNF4A RFX2 TFDP1 NCOR1 FOXD3 FOXP4 SALL1 ZFHX4 HEY1 NFIC GLI1 ATXN3 NR3C2 ATF1 PBX3 NFAT5 MED12 | 1.19e-04 | 1459 | 118 | 21 | GO:0000977 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZBTB4 DACH1 POU2F1 SALL4 HNF4A RFX2 TFDP1 FOXD3 FOXP4 SALL1 ZFHX4 HEY1 NFIC GLI1 NR3C2 ATF1 PBX3 NFAT5 MED12 | 1.62e-04 | 1271 | 118 | 19 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | RBBP8 DAXX PSMD9 HNF4A TFDP1 NCOR1 GTF2H1 SALL1 HEY1 SMARCE1 MAP3K7 MED12 | 1.73e-04 | 582 | 118 | 12 | GO:0140297 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | RBBP8 DAXX HNF4A TFDP1 NCOR1 GTF2H1 SALL1 HEY1 SMARCE1 MED12 | 1.86e-04 | 417 | 118 | 10 | GO:0061629 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | TSHZ3 ZBTB4 DACH1 POU2F1 SALL4 HNF4A RFX2 TFDP1 FOXD3 FOXP4 SALL1 ZFHX4 HEY1 NFIC GLI1 NR3C2 ATF1 PBX3 NFAT5 ZNF292 | 2.19e-04 | 1412 | 118 | 20 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZBTB4 DACH1 POU2F1 SALL4 HNF4A RFX2 FOXD3 FOXP4 SALL1 ZFHX4 HEY1 NFIC GLI1 NR3C2 ATF1 PBX3 NFAT5 MED12 | 3.64e-04 | 1244 | 118 | 18 | GO:0000978 |
| GeneOntologyMolecularFunction | chromatin binding | TSHZ3 POU2F1 HNF4A PHC2 NCOR1 GTF2H1 SALL1 GLI1 SMARCE1 MBD5 NFAT5 TRIM37 MED12 | 4.29e-04 | 739 | 118 | 13 | GO:0003682 |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 8.81e-04 | 32 | 118 | 3 | GO:0015106 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 8.81e-04 | 32 | 118 | 3 | GO:0005452 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 1.05e-03 | 34 | 118 | 3 | GO:0046966 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | POU2F1 ZNF407 SALL4 DAXX PSMD9 RAD54L2 HNF4A RFX2 TFDP1 FOXD3 TSC22D1 SALL1 HEY1 NFIC GLI1 ZFP64 CAPRIN2 NR3C2 ATF1 PBX3 NFAT5 MED12 CAVIN2 ZNF292 | 7.99e-07 | 1390 | 117 | 24 | GO:0045944 |
| GeneOntologyCellularComponent | chromatin | TSHZ3 A1CF POU2F1 SALL4 DAXX HNF4A RFX2 TFDP1 PHC2 NCOR1 FOXD3 FOXP4 SALL1 ZFHX4 HEY1 NFIC SMARCE1 NR3C2 ATF1 POTEI POTEJ PBX3 MAP3K7 NFAT5 | 2.24e-06 | 1480 | 118 | 24 | GO:0000785 |
| GeneOntologyCellularComponent | transcription regulator complex | RBBP8 DACH1 POU2F1 SALL4 TFDP1 NCOR1 FOXD3 GTF2H1 SALL1 ATF1 PBX3 NFAT5 | 1.41e-04 | 596 | 118 | 12 | GO:0005667 |
| GeneOntologyCellularComponent | heterochromatin | 2.71e-04 | 101 | 118 | 5 | GO:0000792 | |
| HumanPheno | Aplasia/hypoplasia of the extremities | CUL4B RBBP8 ZMYM2 ZNF407 SALL4 HUWE1 NEK9 SALL1 GLI1 ACAN FBXO28 ATXN3 SMARCE1 MMP9 MBD5 MAP3K7 MED12 | 6.29e-06 | 813 | 35 | 17 | HP:0009815 |
| HumanPheno | Aplasia involving bones of the extremities | CUL4B RBBP8 ZMYM2 ZNF407 SALL4 HUWE1 SALL1 GLI1 ACAN FBXO28 ATXN3 SMARCE1 MMP9 MBD5 MAP3K7 MED12 | 1.27e-05 | 759 | 35 | 16 | HP:0009825 |
| HumanPheno | Aplasia/hypoplasia involving bones of the extremities | CUL4B RBBP8 ZMYM2 ZNF407 SALL4 HUWE1 SALL1 GLI1 ACAN FBXO28 ATXN3 SMARCE1 MMP9 MBD5 MAP3K7 MED12 | 1.31e-05 | 761 | 35 | 16 | HP:0045060 |
| HumanPheno | Brachydactyly | CUL4B RBBP8 ZMYM2 SALL4 HUWE1 IFIH1 SALL1 GLI1 ACAN FBXO28 SCAPER SMARCE1 MBD5 MAP3K7 MED12 | 1.33e-05 | 670 | 35 | 15 | HP:0001156 |
| HumanPheno | Short digit | CUL4B RBBP8 ZMYM2 SALL4 HUWE1 IFIH1 SALL1 GLI1 ACAN FBXO28 SCAPER SMARCE1 MBD5 MAP3K7 MED12 | 1.38e-05 | 672 | 35 | 15 | HP:0011927 |
| HumanPheno | Abnormal lower limb bone morphology | CUL4B SMARCAL1 ZMYM2 ZNF407 SALL4 HUWE1 WNK1 NEK9 IFIH1 PHLDB1 SALL1 GLI1 ACAN ATXN3 MMP9 MBD5 MAP3K7 | 1.51e-05 | 866 | 35 | 17 | HP:0040069 |
| HumanPheno | Abnormal toe morphology | CUL4B DCAF8 RBBP8 ZMYM2 ZNF407 SALL4 HUWE1 WNK1 NEK9 SALL1 GLI1 ACAN FBXO28 SMARCE1 MBD5 MAP3K7 MED12 | 2.30e-05 | 893 | 35 | 17 | HP:0001780 |
| HumanPheno | Short phalanx of finger | 2.52e-05 | 306 | 35 | 10 | HP:0009803 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the hand | 3.62e-05 | 319 | 35 | 10 | HP:0009767 | |
| HumanPheno | Abnormal finger phalanx morphology | CUL4B RBBP8 ZNF407 SALL4 WNK1 IFIH1 SALL1 GLI1 ACAN FBXO28 SCAPER SMARCE1 MBD5 MAP3K7 MED12 | 4.32e-05 | 738 | 35 | 15 | HP:0005918 |
| HumanPheno | Shallow acetabular fossae | 4.72e-05 | 11 | 35 | 3 | HP:0003182 | |
| HumanPheno | Bulbous nose | 4.80e-05 | 201 | 35 | 8 | HP:0000414 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the upper limbs | CUL4B RBBP8 ZMYM2 SALL4 HUWE1 GLI1 ACAN FBXO28 SMARCE1 MMP9 MBD5 MAP3K7 MED12 | 5.57e-05 | 572 | 35 | 13 | HP:0006496 |
| HumanPheno | Short stature | CUL4B RBBP8 SMARCAL1 ZMYM2 ZNF407 SALL4 HUWE1 HNF4A IFIH1 PHLDB1 SALL1 GLI1 ACAN FBXO28 SCAPER SMARCE1 MMP9 MBD5 MAP3K7 TRIM37 MED12 | 5.70e-05 | 1407 | 35 | 21 | HP:0004322 |
| HumanPheno | Abnormal hand morphology | CUL4B RBBP8 ZMYM2 SALL4 HUWE1 WNK1 NEK9 IFIH1 SALL1 GLI1 ACAN FBXO28 SCAPER SMARCE1 MBD5 MAP3K7 MED12 ZNF292 | 7.44e-05 | 1082 | 35 | 18 | HP:0005922 |
| HumanPheno | Abnormal epiphysis morphology | 7.80e-05 | 279 | 35 | 9 | HP:0005930 | |
| HumanPheno | Brachydactyly (hand) | RBBP8 ZMYM2 SALL4 IFIH1 SALL1 GLI1 ACAN SMARCE1 MBD5 MAP3K7 MED12 | 8.81e-05 | 430 | 35 | 11 | HP:0100667 |
| HumanPheno | Aplasia/hypoplasia involving the skeleton | CUL4B RBBP8 ZMYM2 ZNF407 SALL4 HUWE1 NEK9 IFIH1 SALL1 GLI1 ACAN FBXO28 ATXN3 SMARCE1 MMP9 MBD5 MAP3K7 TRIM37 MED12 ZNF292 | 1.09e-04 | 1343 | 35 | 20 | HP:0009115 |
| HumanPheno | Aplasia/hypoplasia involving bones of the hand | CUL4B RBBP8 ZMYM2 SALL4 HUWE1 GLI1 ACAN FBXO28 SMARCE1 MBD5 MAP3K7 MED12 | 1.45e-04 | 538 | 35 | 12 | HP:0005927 |
| HumanPheno | Microdontia | 1.49e-04 | 175 | 35 | 7 | HP:0000691 | |
| HumanPheno | Abnormal long bone morphology | RBBP8 SMARCAL1 ZNF407 SALL4 WNK1 NEK9 IFIH1 PHLDB1 SALL1 GLI1 ACAN MMP9 MAP3K7 TRIM37 MED12 | 1.53e-04 | 821 | 35 | 15 | HP:0011314 |
| HumanPheno | Abnormal finger morphology | CUL4B RBBP8 ZMYM2 ZNF407 SALL4 HUWE1 WNK1 NEK9 IFIH1 SALL1 GLI1 ACAN FBXO28 SCAPER SMARCE1 LRBA MBD5 MAP3K7 MED12 ZNF292 | 1.73e-04 | 1385 | 35 | 20 | HP:0001167 |
| HumanPheno | Abnormal nasal tip morphology | CUL4B SMARCAL1 ZMYM2 HUWE1 FBXO28 SMARCE1 MBD5 MAP3K7 MED12 ZNF292 | 1.82e-04 | 386 | 35 | 10 | HP:0000436 |
| HumanPheno | Abnormal ureter physiology | 1.94e-04 | 245 | 35 | 8 | HP:0025634 | |
| HumanPheno | Short finger | 2.52e-04 | 325 | 35 | 9 | HP:0009381 | |
| HumanPheno | Abnormally high-pitched voice | 2.70e-04 | 47 | 35 | 4 | HP:0001620 | |
| HumanPheno | Abnormal morphology of bones of the lower limbs | SMARCAL1 ZNF407 SALL4 NEK9 IFIH1 PHLDB1 SALL1 ACAN MMP9 MAP3K7 | 3.79e-04 | 422 | 35 | 10 | HP:0040066 |
| HumanPheno | Broad phalanx | 4.39e-04 | 148 | 35 | 6 | HP:0006009 | |
| HumanPheno | Broad phalanges of the hand | 4.39e-04 | 148 | 35 | 6 | HP:0009768 | |
| HumanPheno | Sandal gap | 4.44e-04 | 96 | 35 | 5 | HP:0001852 | |
| HumanPheno | Shoulder muscle hypoplasia | 4.53e-04 | 5 | 35 | 2 | HP:0008952 | |
| HumanPheno | Aplasia/Hypoplasia involving the shoulder musculature | 4.53e-04 | 5 | 35 | 2 | HP:0001464 | |
| HumanPheno | Broad finger | 5.44e-04 | 154 | 35 | 6 | HP:0001500 | |
| HumanPheno | Abnormality of lower limb joint | CUL4B RBBP8 SMARCAL1 ZNF407 WNK1 NEK9 IFIH1 PHLDB1 SALL1 GLI1 ACAN FBXO28 MMP9 MBD5 MAP3K7 MED12 | 5.50e-04 | 1027 | 35 | 16 | HP:0100491 |
| HumanPheno | Limb undergrowth | 5.70e-04 | 444 | 35 | 10 | HP:0009826 | |
| HumanPheno | Broad long bones | 6.03e-04 | 157 | 35 | 6 | HP:0005622 | |
| HumanPheno | Macrostomia | 6.08e-04 | 220 | 35 | 7 | HP:0000181 | |
| HumanPheno | Wide mouth | 6.08e-04 | 220 | 35 | 7 | HP:0000154 | |
| HumanPheno | Aplasia/Hypoplasia of fingers | 6.10e-04 | 366 | 35 | 9 | HP:0006265 | |
| HumanPheno | Vesicoureteral reflux | 6.25e-04 | 221 | 35 | 7 | HP:0000076 | |
| HumanPheno | Broad nasal tip | 6.45e-04 | 159 | 35 | 6 | HP:0000455 | |
| HumanPheno | Abnormality of the tubular bones | ZNF407 SALL4 NEK9 IFIH1 PHLDB1 SALL1 GLI1 ACAN MMP9 MAP3K7 TRIM37 MED12 | 6.63e-04 | 632 | 35 | 12 | HP:0100713 |
| HumanPheno | Abnormality of the long tubular bones | ZNF407 SALL4 NEK9 IFIH1 PHLDB1 SALL1 GLI1 ACAN MMP9 MAP3K7 TRIM37 MED12 | 6.63e-04 | 632 | 35 | 12 | HP:0100714 |
| HumanPheno | Abnormal pelvic girdle bone morphology | RBBP8 SMARCAL1 ZNF407 WNK1 NEK9 IFIH1 PHLDB1 GLI1 ACAN MMP9 MBD5 MAP3K7 MED12 | 6.75e-04 | 730 | 35 | 13 | HP:0002644 |
| HumanPheno | Bilateral camptodactyly | 6.76e-04 | 6 | 35 | 2 | HP:0005617 | |
| HumanPheno | Pseudohypoaldosteronism | 6.76e-04 | 6 | 35 | 2 | HP:0008242 | |
| HumanPheno | Aplasia/Hypoplasia involving the musculature of the extremities | 6.76e-04 | 6 | 35 | 2 | HP:0009128 | |
| HumanPheno | Aplasia/Hypoplasia involving the musculature of the upper limbs | 6.76e-04 | 6 | 35 | 2 | HP:0001467 | |
| HumanPheno | Abnormal pitch | 6.93e-04 | 60 | 35 | 4 | HP:5200005 | |
| HumanPheno | Synostosis of carpal bones | 6.93e-04 | 26 | 35 | 3 | HP:0005048 | |
| HumanPheno | Aplasia/Hypoplasia involving bones of the feet | 7.32e-04 | 298 | 35 | 8 | HP:0006494 | |
| HumanPheno | Abnormal dental morphology | 7.49e-04 | 299 | 35 | 8 | HP:0006482 | |
| HumanPheno | Metaphyseal widening | 8.36e-04 | 232 | 35 | 7 | HP:0003016 | |
| HumanPheno | Abnormality of the ureter | 8.49e-04 | 383 | 35 | 9 | HP:0000069 | |
| HumanPheno | Abnormal hip bone morphology | RBBP8 SMARCAL1 ZNF407 WNK1 NEK9 IFIH1 PHLDB1 ACAN MMP9 MBD5 MAP3K7 MED12 | 8.93e-04 | 653 | 35 | 12 | HP:0003272 |
| HumanPheno | Atrophic gastritis | 9.43e-04 | 7 | 35 | 2 | HP:0002582 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the lower limbs | 9.57e-04 | 474 | 35 | 10 | HP:0006493 | |
| HumanPheno | Deviation of the hand or of fingers of the hand | CUL4B RBBP8 ZMYM2 SALL4 NEK9 SALL1 SCAPER MBD5 MAP3K7 MED12 ZNF292 | 9.62e-04 | 564 | 35 | 11 | HP:0009484 |
| HumanPheno | Abnormal localization of kidney | 1.05e-03 | 241 | 35 | 7 | HP:0100542 | |
| HumanPheno | Abnormal neck morphology | CUL4B SMARCAL1 ZMYM2 SALL4 HUWE1 NEK9 PHLDB1 SALL1 ACAN SCAPER MBD5 MAP3K7 MED12 | 1.08e-03 | 766 | 35 | 13 | HP:0025668 |
| HumanPheno | Clinodactyly | CUL4B RBBP8 ZMYM2 HUWE1 SALL1 SCAPER SMARCE1 MBD5 MAP3K7 MED12 ZNF292 | 1.11e-03 | 574 | 35 | 11 | HP:0030084 |
| HumanPheno | Cupped ear | 1.18e-03 | 69 | 35 | 4 | HP:0000378 | |
| HumanPheno | Short chin | 1.18e-03 | 69 | 35 | 4 | HP:0000331 | |
| HumanPheno | Abnormal Intonation | 1.18e-03 | 69 | 35 | 4 | HP:5200010 | |
| HumanPheno | Abnormal hair pattern | CUL4B ZNF407 SALL4 HUWE1 IFIH1 FBXO28 SCAPER SMARCE1 MBD5 MAP3K7 MED12 ZNF292 | 1.22e-03 | 676 | 35 | 12 | HP:0010720 |
| HumanPheno | Abnormal curvature of the vertebral column | CUL4B RBBP8 SMARCAL1 ZMYM2 HMBS ZNF407 SALL4 HUWE1 WNK1 NEK9 IFIH1 ACAN FBXO28 SMARCE1 MBD5 MAP3K7 MED12 | 1.26e-03 | 1219 | 35 | 17 | HP:0010674 |
| HumanPheno | Talipes | CUL4B SMARCAL1 ZMYM2 SALL4 HUWE1 NEK9 IFIH1 SALL1 SCAPER MBD5 MAP3K7 | 1.27e-03 | 583 | 35 | 11 | HP:0001883 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS | 3.92e-05 | 31 | 88 | 4 | M27393 | |
| Pathway | REACTOME_POU5F1_OCT4_SOX2_NANOG_ACTIVATE_GENES_RELATED_TO_PROLIFERATION | 6.43e-05 | 13 | 88 | 3 | M27209 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | DENND4A DACH1 ZMYM2 POU2F1 ZNF407 SALL4 DAXX HNF4A RFX2 TFDP1 PWP1 GTF2H1 NFIC GLI1 ZFP64 SMARCE1 PBX3 TARBP2 ZNF292 | 1.40e-10 | 877 | 118 | 19 | 20211142 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | USP34 RBBP8 VPS50 C19orf47 ZMYM2 DAXX HUWE1 RAD54L2 CCDC6 WNK1 NCOR1 SALL1 POTEI POTEJ SIPA1L2 TRIM37 | 1.73e-10 | 588 | 118 | 16 | 38580884 |
| Pubmed | USP34 TSHZ3 RBBP8 ZMYM2 HUWE1 NEK9 TFDP1 NCOR1 SALL1 ZFHX4 ZNF608 LRBA GOLGA5 MED12 | 1.77e-10 | 418 | 118 | 14 | 34709266 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | TSHZ3 ZMYM2 POU2F1 RAD54L2 TFDP1 NCOR1 FOXP4 SALL1 ZFHX4 ZNF608 NFIC SMARCE1 MED12 | 2.42e-10 | 351 | 118 | 13 | 38297188 |
| Pubmed | 4.40e-10 | 83 | 118 | 8 | 28794006 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SMARCAL1 DACH1 ZMYM2 POU2F1 HUWE1 RFX2 TFDP1 NCOR1 FOXD3 FOXP4 SALL1 MDN1 ZFHX4 NFIC GLI1 SMARCE1 ATF1 PBX3 | 7.34e-10 | 857 | 118 | 18 | 25609649 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CUL4B EVL RBBP8 TBC1D2 ZMYM2 POU2F1 DAXX HUWE1 ARHGAP35 CCDC6 PHC2 PWP1 NCOR1 MDN1 NFIC PRRC2A CDH17 | 1.17e-09 | 774 | 118 | 17 | 15302935 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | TSHZ3 ZBTB4 POU2F1 HNF4A RFX2 TFDP1 FOXD3 FOXP4 TSC22D1 SALL1 ZFHX4 HEY1 NFIC GLI1 NR3C2 ATF1 PBX3 NFAT5 | 1.82e-09 | 908 | 118 | 18 | 19274049 |
| Pubmed | USP34 TSHZ3 ZMYM2 PHC2 MSI2 PWP1 NCOR1 FOXP4 MDN1 ZFHX4 BOD1L1 | 3.64e-09 | 282 | 118 | 11 | 23667531 | |
| Pubmed | CUL4B CDK16 EVL RBBP8 PKP4 SPECC1 TFDP1 PWP1 CYB5B HEATR6 MDN1 SMARCE1 COPS6 PLIN3 CAVIN2 | 4.44e-09 | 634 | 118 | 15 | 34591612 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EVL CDC42BPA DCAF8 DEPTOR HUWE1 ARHGAP35 NEK9 MSI2 FOXP4 TSC22D1 PHLDB1 ZNF608 NFIC ZFP64 SLX4IP BOD1L1 LRBA MBD5 PBX3 NFAT5 SLC4A5 AGAP1 | 5.50e-09 | 1489 | 118 | 22 | 28611215 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA6C USP34 CDC42BPA ZBTB4 C19orf47 TBC1D25 HUWE1 ARHGAP35 WNK1 PHC2 NCOR1 PHLDB1 MDN1 SLC45A3 GLI1 LRBA SIPA1L2 MBD5 MED12 | 6.27e-09 | 1105 | 118 | 19 | 35748872 |
| Pubmed | ZMYM2 POU2F1 SALL4 RFX2 TFDP1 NCOR1 TSC22D1 SALL1 HEY1 ZFP64 SCAPER SMARCE1 ATF1 PBX3 NFAT5 ZNF292 | 1.60e-08 | 808 | 118 | 16 | 20412781 | |
| Pubmed | 3.81e-08 | 28 | 118 | 5 | 29365100 | ||
| Pubmed | MXRA5 SMARCAL1 ZMYM2 MUC16 TBC1D25 CYB5B NCOR1 PHLDB1 SALL1 MDN1 SMARCE1 POTEJ CAVIN2 CDH17 | 3.84e-08 | 638 | 118 | 14 | 31182584 | |
| Pubmed | USP34 RBBP8 RAD54L2 GTF2H1 MDN1 CDC42SE2 NFIC SLX4IP SMARCE1 BOD1L1 MED12 CAVIN2 | 5.07e-08 | 453 | 118 | 12 | 29656893 | |
| Pubmed | USP34 DCAF8 SYNM ZBTB4 ZMYM2 HUWE1 RAD54L2 CCDC6 TUBGCP5 SPECC1 HEATR6 HEY1 SMARCE1 LRBA PBX3 PRRC2A TRIM37 AGAP1 ZNF292 | 6.84e-08 | 1285 | 118 | 19 | 35914814 | |
| Pubmed | TSHZ3 CDC42BPA DACH1 ZMYM2 POU2F1 RAD54L2 HNF4A TFDP1 MSI2 PWP1 NCOR1 FOXP4 SALL1 ZFHX4 ZNF608 NFIC SLX4IP SMARCE1 ATF1 PRRC2A | 7.23e-08 | 1429 | 118 | 20 | 35140242 | |
| Pubmed | POU2F1 HNF4A TFDP1 FOXD3 FOXP4 HEY1 GLI1 ZFP64 SMARCE1 NR3C2 PBX3 COPS6 NFAT5 ZNF292 | 1.40e-07 | 709 | 118 | 14 | 22988430 | |
| Pubmed | PIKES Analysis Reveals Response to Degraders and Key Regulatory Mechanisms of the CRL4 Network. | 6.99e-07 | 49 | 118 | 5 | 31973889 | |
| Pubmed | SYNM ZBTB4 ZNF407 ARHGAP35 WNK1 TUBGCP5 NEK9 TSC22D1 SCAPER MBD5 MED12 | 1.02e-06 | 493 | 118 | 11 | 15368895 | |
| Pubmed | CUL4B USP34 DCAF8 PKP4 VPS50 TUBGCP5 TFDP1 FOXP4 GTF2H1 ZFHX4 ZNF608 CAPRIN2 SCAPER SMARCE1 SIPA1L2 TARBP2 | 1.23e-06 | 1116 | 118 | 16 | 31753913 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDK16 DENND4A CDC42BPA C19orf47 CCDC6 ARHGEF17 WNK1 SPECC1 NEK9 PHLDB1 MDN1 BOD1L1 NR3C2 SIPA1L2 | 1.41e-06 | 861 | 118 | 14 | 36931259 |
| Pubmed | 1.55e-06 | 104 | 118 | 6 | 9205841 | ||
| Pubmed | 1.79e-06 | 59 | 118 | 5 | 19295130 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | DEPTOR PKP4 ZNF407 MSI2 CYB5B NCOR1 CDC42SE2 SLC45A3 MBD5 PRRC2A AGAP1 | 2.28e-06 | 536 | 118 | 11 | 15840001 |
| Pubmed | DEPTOR PKP4 ZNF407 MSI2 CYB5B NCOR1 CDC42SE2 SLC45A3 MBD5 PRRC2A AGAP1 | 2.36e-06 | 538 | 118 | 11 | 10512203 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | CDK16 EVL SCHIP1 DCAF8 DEPTOR DAXX CCDC6 WNK1 NEK9 PHLDB1 SMARCE1 MAP3K7 TRIM37 MED12 AGAP1 | 2.48e-06 | 1038 | 118 | 15 | 26673895 |
| Pubmed | DACH1 HUWE1 ARHGAP35 NEK9 NCOR1 SMARCE1 BOD1L1 LRBA PRRC2A MED12 PLIN3 | 2.87e-06 | 549 | 118 | 11 | 38280479 | |
| Pubmed | Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery. | 4.21e-06 | 32 | 118 | 4 | 16964240 | |
| Pubmed | 4.25e-06 | 191 | 118 | 7 | 24146773 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | ZMYM2 HUWE1 RAD54L2 TFDP1 SALL1 ZFHX4 NFIC ZFP64 ATF1 PBX3 NFAT5 | 5.07e-06 | 583 | 118 | 11 | 29844126 |
| Pubmed | 7.63e-06 | 37 | 118 | 4 | 16949367 | ||
| Pubmed | 8.19e-06 | 12 | 118 | 3 | 28446751 | ||
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 1.01e-05 | 218 | 118 | 7 | 33378226 | |
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 31301300 | ||
| Pubmed | Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts. | 1.14e-05 | 2 | 118 | 2 | 19476507 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 19898610 | ||
| Pubmed | Impact of GTF2H1 and RAD54L2 polymorphisms on the risk of lung cancer in the Chinese Han population. | 1.14e-05 | 2 | 118 | 2 | 36384536 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 18410405 | ||
| Pubmed | The Interaction Mode of the Acidic Region of the Cell Cycle Transcription Factor DP1 with TFIIH. | 1.14e-05 | 2 | 118 | 2 | 27825926 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 12395297 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 19350679 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 25742474 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 17295837 | ||
| Pubmed | CDC42BPA PKP4 ARHGEF12 ZMYM2 DAXX SPECC1 PHC2 PWP1 GTF2H1 MDN1 FBXO28 SMARCE1 ATF1 PRRC2A TARBP2 MED12 AGAP1 | 1.24e-05 | 1497 | 118 | 17 | 31527615 | |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 1.46e-05 | 321 | 118 | 8 | 32098917 | |
| Pubmed | CDK16 CDC42BPA PKP4 ARHGEF12 ZMYM2 HUWE1 ARHGAP35 CCDC6 ARHGEF17 FBXO28 SMARCE1 MAP3K7 PRRC2A | 1.47e-05 | 916 | 118 | 13 | 32203420 | |
| Pubmed | ATRX proximal protein associations boast roles beyond histone deposition. | 1.52e-05 | 91 | 118 | 5 | 34780483 | |
| Pubmed | 1.60e-05 | 234 | 118 | 7 | 36243803 | ||
| Pubmed | TSHZ3 GLRX2 SALL4 PSMD9 SPECC1 TSC22D1 ZNF608 FBXO28 CLTB NEURL1B MMP9 SIPA1L2 PBX3 TRIM37 CAVIN2 | 1.62e-05 | 1215 | 118 | 15 | 15146197 | |
| Pubmed | EVL DACH1 ZMYM2 POU2F1 RAD54L2 NCOR1 NFIC CLTB SMARCE1 ATF1 PRRC2A MED12 PLIN3 ZNF292 | 2.34e-05 | 1103 | 118 | 14 | 34189442 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 2.37e-05 | 167 | 118 | 6 | 20362541 | |
| Pubmed | CUL4B DCAF8 ARHGAP35 TFDP1 MSI2 NCOR1 MDN1 CROCC2 SCAPER MBD5 TARBP2 | 2.40e-05 | 689 | 118 | 11 | 36543142 | |
| Pubmed | 3.18e-05 | 106 | 118 | 5 | 19394292 | ||
| Pubmed | 3.37e-05 | 263 | 118 | 7 | 20932939 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 19440552 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 17079677 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 35921902 | ||
| Pubmed | IQCJ-SCHIP1, a novel fusion transcript encoding a calmodulin-binding IQ motif protein. | 3.42e-05 | 3 | 118 | 2 | 17045569 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 33453283 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 27471257 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 17897957 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 12419962 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 27956576 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 24465431 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 23825698 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 37544354 | ||
| Pubmed | Next-generation sequencing to generate interactome datasets. | DCAF8 DEPTOR PKP4 DACH1 PSMD9 RAD54L2 RFX2 PHC2 CYB5B FOXP4 FBXO28 ZFP64 SMARCE1 TNXB | 3.58e-05 | 1147 | 118 | 14 | 21516116 |
| Pubmed | 3.80e-05 | 268 | 118 | 7 | 33640491 | ||
| Pubmed | 3.95e-05 | 183 | 118 | 6 | 36129980 | ||
| Pubmed | Hox5 interacts with Plzf to restrict Shh expression in the developing forelimb. | 4.16e-05 | 20 | 118 | 3 | 24218595 | |
| Pubmed | 4.16e-05 | 20 | 118 | 3 | 33355139 | ||
| Pubmed | 4.16e-05 | 20 | 118 | 3 | 31155351 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CUL4B CDK16 DENND4A VPS50 TBC1D25 PSMD9 WNK1 NEK9 GTF2H1 CLTB DCAF11 GOLGA5 COPS6 TARBP2 AGAP1 | 4.23e-05 | 1321 | 118 | 15 | 27173435 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 5.22e-05 | 497 | 118 | 9 | 36774506 | |
| Pubmed | 6.48e-05 | 396 | 118 | 8 | 26687479 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | DCAF8 HUWE1 CCDC6 ARHGEF17 TUBGCP5 SMARCE1 SIPA1L2 ANKRD40 PRRC2A TRIM37 | 6.73e-05 | 639 | 118 | 10 | 23443559 |
| Pubmed | Regulation and function of Spalt proteins during animal development. | 6.82e-05 | 4 | 118 | 2 | 19247946 | |
| Pubmed | Myostatin induces interstitial fibrosis in the heart via TAK1 and p38. | 6.82e-05 | 4 | 118 | 2 | 25725788 | |
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 27979964 | ||
| Pubmed | Differential DNA methylation patterns in human Schlemm's canal endothelial cells with glaucoma. | 6.82e-05 | 4 | 118 | 2 | 32606567 | |
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 21543328 | ||
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 16545361 | ||
| Pubmed | A novel dual signaling axis for NSP 5a3a induced apoptosis in head and neck carcinoma. | 6.82e-05 | 4 | 118 | 2 | 22170762 | |
| Pubmed | Knockdown of LI-cadherin alters expression of matrix metalloproteinase-2 and -9 and galectin-3. | 6.82e-05 | 4 | 118 | 2 | 27035870 | |
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 7.00e-05 | 125 | 118 | 5 | 32891193 | |
| Pubmed | USP34 CDC42BPA SYNM MUC16 PODXL2 HUWE1 NCOR1 LRBA GOLGA5 MAP3K7 AGAP1 | 7.07e-05 | 777 | 118 | 11 | 35844135 | |
| Pubmed | Autoubiquitination of the 26S proteasome on Rpn13 regulates breakdown of ubiquitin conjugates. | 7.71e-05 | 66 | 118 | 4 | 24811749 | |
| Pubmed | 7.83e-05 | 407 | 118 | 8 | 12693553 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 8.38e-05 | 411 | 118 | 8 | 35182466 | |
| Pubmed | 9.35e-05 | 26 | 118 | 3 | 19590010 | ||
| Pubmed | 9.90e-05 | 421 | 118 | 8 | 36976175 | ||
| Pubmed | A global genomic transcriptional code associated with CNS-expressed genes. | 1.11e-04 | 318 | 118 | 7 | 16919269 | |
| Pubmed | EVL DENND4A RBBP8 RAD54L2 CYB5B NCOR1 MDN1 ZNF608 CAPRIN2 BOD1L1 POTEI POTEJ SIPA1L2 CAVIN2 ZNF292 | 1.13e-04 | 1442 | 118 | 15 | 35575683 | |
| Pubmed | Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway. | 1.13e-04 | 5 | 118 | 2 | 21076395 | |
| Pubmed | 1.13e-04 | 5 | 118 | 2 | 18550753 | ||
| Pubmed | 1.13e-04 | 5 | 118 | 2 | 36759189 | ||
| Pubmed | 1.13e-04 | 5 | 118 | 2 | 9738006 | ||
| Pubmed | 1.13e-04 | 5 | 118 | 2 | 14978255 | ||
| Interaction | RCOR1 interactions | CUL4B USP34 TSHZ3 RBBP8 VPS50 ZMYM2 PSMD9 HUWE1 NEK9 NCOR1 SALL1 ZFHX4 SMARCE1 LRBA GOLGA5 MED12 | 2.76e-08 | 494 | 117 | 16 | int:RCOR1 |
| Interaction | SOX2 interactions | CUL4B USP34 TSHZ3 CDC42BPA PKP4 DACH1 ZMYM2 POU2F1 SALL4 PHC2 MSI2 PWP1 NCOR1 FOXP4 SALL1 MDN1 ZFHX4 ZNF608 NFIC CROCC2 ATXN3 SMARCE1 BOD1L1 ATF1 SIPA1L2 TARBP2 ZNF292 | 3.19e-08 | 1422 | 117 | 27 | int:SOX2 |
| Interaction | SOX5 interactions | TSHZ3 DACH1 POU2F1 NCOR1 FOXP4 ZFHX4 ZNF608 NFIC ANKRD40 PRRC2A | 3.63e-08 | 162 | 117 | 10 | int:SOX5 |
| Interaction | NR3C1 interactions | MXRA5 SMARCAL1 ZMYM2 MUC16 POU2F1 TBC1D25 DAXX RAD54L2 CCDC6 PWP1 CYB5B NCOR1 PHLDB1 SALL1 MDN1 CLTB SMARCE1 NR3C2 POTEJ COPS6 CAVIN2 CDH17 | 3.83e-08 | 974 | 117 | 22 | int:NR3C1 |
| Interaction | PHF21A interactions | CUL4B USP34 TSHZ3 RBBP8 VPS50 ZMYM2 PSMD9 HUWE1 NEK9 SALL1 ZFHX4 LRBA GOLGA5 | 1.01e-07 | 343 | 117 | 13 | int:PHF21A |
| Interaction | FOXP1 interactions | CUL4B ZMYM2 HNF4A TFDP1 FOXP4 SALL1 ZFHX4 NFIC CLTB NFAT5 TARBP2 | 2.97e-07 | 256 | 117 | 11 | int:FOXP1 |
| Interaction | FEV interactions | DACH1 POU2F1 RAD54L2 NCOR1 FOXP4 SALL1 ZFHX4 ZNF608 NFIC ATF1 | 3.01e-07 | 203 | 117 | 10 | int:FEV |
| Interaction | HDAC1 interactions | CUL4B TSHZ3 CDC42BPA RBBP8 DACH1 ZMYM2 POU2F1 SALL4 DAXX CCDC6 NEK9 TFDP1 NCOR1 SALL1 ZFHX4 ZNF608 GLI1 ZFP64 SMARCE1 LRBA GOLGA5 MED12 | 3.58e-07 | 1108 | 117 | 22 | int:HDAC1 |
| Interaction | PAX7 interactions | 6.37e-07 | 124 | 117 | 8 | int:PAX7 | |
| Interaction | TLX3 interactions | DENND4A POU2F1 PWP1 NCOR1 FOXP4 GTF2H1 SALL1 ZFHX4 ZNF608 NFIC SMARCE1 | 1.05e-06 | 291 | 117 | 11 | int:TLX3 |
| Interaction | SOX17 interactions | 1.34e-06 | 95 | 117 | 7 | int:SOX17 | |
| Interaction | PAX6 interactions | TSHZ3 DACH1 ZMYM2 POU2F1 CCDC6 TFDP1 NCOR1 SALL1 ZFHX4 ZNF608 NFIC SMARCE1 | 1.49e-06 | 366 | 117 | 12 | int:PAX6 |
| Interaction | EN1 interactions | 3.60e-06 | 110 | 117 | 7 | int:EN1 | |
| Interaction | AR interactions | CUL4B USP34 CDC42BPA ZMYM2 POU2F1 DAXX HUWE1 RAD54L2 HNF4A NEK9 NCOR1 FOXP4 GTF2H1 MDN1 ZNF608 NFIC SMARCE1 NR3C2 MED12 | 4.25e-06 | 992 | 117 | 19 | int:AR |
| Interaction | HNF4A interactions | DACH1 MUC19 ZMYM2 RAD54L2 HNF4A NCOR1 GTF2H1 ZNF608 SLX4IP SMARCE1 | 4.70e-06 | 275 | 117 | 10 | int:HNF4A |
| Interaction | ERG interactions | 6.21e-06 | 223 | 117 | 9 | int:ERG | |
| Interaction | NFIX interactions | 7.17e-06 | 227 | 117 | 9 | int:NFIX | |
| Interaction | TEAD1 interactions | 8.76e-06 | 176 | 117 | 8 | int:TEAD1 | |
| Interaction | TEAD2 interactions | 1.09e-05 | 130 | 117 | 7 | int:TEAD2 | |
| Interaction | GSC interactions | 1.16e-05 | 87 | 117 | 6 | int:GSC | |
| Interaction | DZIP3 interactions | 1.16e-05 | 183 | 117 | 8 | int:DZIP3 | |
| Interaction | LHX3 interactions | 1.26e-05 | 185 | 117 | 8 | int:LHX3 | |
| Interaction | POMZP3 interactions | 1.56e-05 | 9 | 117 | 3 | int:POMZP3 | |
| Interaction | CREB1 interactions | 1.76e-05 | 254 | 117 | 9 | int:CREB1 | |
| Interaction | FOXL1 interactions | 1.91e-05 | 196 | 117 | 8 | int:FOXL1 | |
| Interaction | USP7 interactions | CUL4B CDK16 CDC42BPA DEPTOR PKP4 DAXX HUWE1 CCDC6 ARHGEF17 PHC2 PWP1 FOXD3 TSC22D1 SALL1 MDN1 GLI1 CLTB ATXN3 LRBA COPS6 SLC4A5 | 2.00e-05 | 1313 | 117 | 21 | int:USP7 |
| Interaction | FOXP4 interactions | 2.29e-05 | 98 | 117 | 6 | int:FOXP4 | |
| Interaction | DCAF8 interactions | 2.87e-05 | 151 | 117 | 7 | int:DCAF8 | |
| Interaction | KDM1A interactions | USP34 TSHZ3 RBBP8 VPS50 ZMYM2 PSMD9 HUWE1 HNF4A NEK9 TFDP1 PHC2 NCOR1 ZFHX4 ZNF608 LRBA GOLGA5 MED12 | 3.03e-05 | 941 | 117 | 17 | int:KDM1A |
| Interaction | RPL7P32 interactions | 3.04e-05 | 11 | 117 | 3 | int:RPL7P32 | |
| Interaction | POU5F1 interactions | CUL4B USP34 ZMYM2 MUC16 SALL4 HUWE1 RFX2 SPECC1 FOXD3 FOXP4 SALL1 SMARCE1 SIPA1L2 | 3.50e-05 | 584 | 117 | 13 | int:POU5F1 |
| Interaction | SOX6 interactions | 3.69e-05 | 157 | 117 | 7 | int:SOX6 | |
| Interaction | FOXP2 interactions | 5.42e-05 | 70 | 117 | 5 | int:FOXP2 | |
| Interaction | FOXC1 interactions | 5.62e-05 | 228 | 117 | 8 | int:FOXC1 | |
| Interaction | YAP1 interactions | DACH1 HUWE1 ARHGAP35 CCDC6 NEK9 NCOR1 GLI1 ATXN3 SMARCE1 BOD1L1 POTEI POTEJ MAP3K7 NFAT5 PRRC2A TRIM37 MED12 PLIN3 | 5.95e-05 | 1095 | 117 | 18 | int:YAP1 |
| Interaction | YWHAH interactions | CDK16 DENND4A CDC42BPA C19orf47 TBC1D25 HUWE1 CCDC6 ARHGEF17 WNK1 SPECC1 IFIH1 PHLDB1 BOD1L1 NR3C2 LRBA SIPA1L2 MAP3K7 AGAP1 | 6.46e-05 | 1102 | 117 | 18 | int:YWHAH |
| Interaction | TLE3 interactions | CUL4B TSHZ3 RBBP8 ZBTB4 RAD54L2 NCOR1 SALL1 ZNF608 NFIC ANKRD40 | 6.88e-05 | 376 | 117 | 10 | int:TLE3 |
| Interaction | SP7 interactions | 7.14e-05 | 304 | 117 | 9 | int:SP7 | |
| Interaction | ELK3 interactions | 7.18e-05 | 120 | 117 | 6 | int:ELK3 | |
| Interaction | TLX1 interactions | 7.34e-05 | 175 | 117 | 7 | int:TLX1 | |
| Interaction | SIN3A interactions | CUL4B ZBTB4 DACH1 ZMYM2 DAXX NCOR1 SMARCE1 BOD1L1 PBX3 COPS6 | 7.52e-05 | 380 | 117 | 10 | int:SIN3A |
| Interaction | MEN1 interactions | CUL4B CDC42BPA RBBP8 SMARCAL1 ZMYM2 DAXX ARHGEF17 PWP1 NCOR1 MDN1 ZNF608 NFIC SMARCE1 BOD1L1 PRRC2A MED12 CAVIN2 | 9.18e-05 | 1029 | 117 | 17 | int:MEN1 |
| Interaction | LHX2 interactions | 9.71e-05 | 183 | 117 | 7 | int:LHX2 | |
| Interaction | SMG7 interactions | 1.03e-04 | 319 | 117 | 9 | int:SMG7 | |
| Interaction | FHL2 interactions | 1.06e-04 | 396 | 117 | 10 | int:FHL2 | |
| Interaction | ERCC4 interactions | 1.09e-04 | 81 | 117 | 5 | int:ERCC4 | |
| Interaction | UBE2I interactions | RBBP8 DACH1 ZMYM2 POU2F1 DAXX PSMD9 RAD54L2 CCDC6 HNF4A WNK1 NCOR1 SALL1 NR3C2 | 1.10e-04 | 654 | 117 | 13 | int:UBE2I |
| Interaction | NANOG interactions | USP34 ZMYM2 MUC16 SALL4 HUWE1 SPECC1 NCOR1 SALL1 MDN1 SIPA1L2 MED12 | 1.14e-04 | 481 | 117 | 11 | int:NANOG |
| Interaction | SOX7 interactions | 1.16e-04 | 82 | 117 | 5 | int:SOX7 | |
| Interaction | RBPJ interactions | 1.19e-04 | 254 | 117 | 8 | int:RBPJ | |
| Interaction | RBBP4 interactions | CUL4B TSHZ3 TBC1D2 ZMYM2 SALL4 HUWE1 CCDC6 TFDP1 NCOR1 SALL1 ATXN3 SMARCE1 | 1.26e-04 | 573 | 117 | 12 | int:RBBP4 |
| Interaction | PRDM1 interactions | 1.30e-04 | 84 | 117 | 5 | int:PRDM1 | |
| Interaction | PAX2 interactions | 1.37e-04 | 85 | 117 | 5 | int:PAX2 | |
| Interaction | ATM interactions | 1.42e-04 | 333 | 117 | 9 | int:ATM | |
| Interaction | NFIC interactions | 2.27e-04 | 210 | 117 | 7 | int:NFIC | |
| Interaction | ZEB2 interactions | 2.31e-04 | 95 | 117 | 5 | int:ZEB2 | |
| Interaction | SETDB1 interactions | 2.55e-04 | 214 | 117 | 7 | int:SETDB1 | |
| Interaction | NCOR1 interactions | 2.70e-04 | 363 | 117 | 9 | int:NCOR1 | |
| Interaction | NUP43 interactions | USP34 RBBP8 MUC19 ZMYM2 RAD54L2 TFDP1 NCOR1 ZNF608 SMARCE1 BOD1L1 MED12 ZNF292 | 2.81e-04 | 625 | 117 | 12 | int:NUP43 |
| Interaction | TOP3B interactions | SEMA6C USP34 CDC42BPA ZBTB4 C19orf47 TBC1D25 HUWE1 ARHGAP35 WNK1 PHC2 NCOR1 PHLDB1 MDN1 SLC45A3 GLI1 LRBA SIPA1L2 MBD5 PRRC2A MED12 | 2.93e-04 | 1470 | 117 | 20 | int:TOP3B |
| Interaction | KLF15 interactions | 2.94e-04 | 290 | 117 | 8 | int:KLF15 | |
| Interaction | DDA1 interactions | 2.99e-04 | 368 | 117 | 9 | int:DDA1 | |
| Interaction | DENND1A interactions | 3.08e-04 | 101 | 117 | 5 | int:DENND1A | |
| Interaction | SATB2 interactions | 3.34e-04 | 159 | 117 | 6 | int:SATB2 | |
| Interaction | DACH1 interactions | 3.52e-04 | 104 | 117 | 5 | int:DACH1 | |
| Interaction | CELA1 interactions | 3.53e-04 | 24 | 117 | 3 | int:CELA1 | |
| Interaction | USP21 interactions | 3.57e-04 | 161 | 117 | 6 | int:USP21 | |
| Interaction | ZBTB21 interactions | 3.57e-04 | 161 | 117 | 6 | int:ZBTB21 | |
| Interaction | SCRN1 interactions | 3.59e-04 | 58 | 117 | 4 | int:SCRN1 | |
| Interaction | MAP1LC3B interactions | TBC1D25 DAXX PSMD9 ARHGEF17 NEK9 IFIH1 NCOR1 NFIC LRBA COPS6 PRRC2A | 3.67e-04 | 551 | 117 | 11 | int:MAP1LC3B |
| Interaction | SEM1 interactions | 3.69e-04 | 162 | 117 | 6 | int:SEM1 | |
| Interaction | DYRK1A interactions | USP34 TBC1D2 HUWE1 RAD54L2 ARHGEF17 GTF2H1 GLI1 CLTB LRBA SIPA1L2 AGAP1 | 3.73e-04 | 552 | 117 | 11 | int:DYRK1A |
| Interaction | KLF3 interactions | 3.74e-04 | 228 | 117 | 7 | int:KLF3 | |
| Interaction | NCKAP5L interactions | 3.85e-04 | 106 | 117 | 5 | int:NCKAP5L | |
| Interaction | BMAL1 interactions | 4.75e-04 | 111 | 117 | 5 | int:BMAL1 | |
| Interaction | PAX8 interactions | 4.75e-04 | 111 | 117 | 5 | int:PAX8 | |
| Interaction | NRIP1 interactions | 4.76e-04 | 170 | 117 | 6 | int:NRIP1 | |
| Interaction | FOS interactions | 4.78e-04 | 312 | 117 | 8 | int:FOS | |
| Interaction | EGR2 interactions | 4.91e-04 | 171 | 117 | 6 | int:EGR2 | |
| Interaction | HDAC2 interactions | CUL4B RBBP8 ZMYM2 SALL4 DAXX HUWE1 WNK1 TFDP1 PHC2 NCOR1 SALL1 GLI1 SMARCE1 LRBA | 4.92e-04 | 865 | 117 | 14 | int:HDAC2 |
| Interaction | TUFT1 interactions | 4.94e-04 | 63 | 117 | 4 | int:TUFT1 | |
| Interaction | TBR1 interactions | 5.16e-04 | 113 | 117 | 5 | int:TBR1 | |
| Interaction | SIPA1L1 interactions | 5.39e-04 | 174 | 117 | 6 | int:SIPA1L1 | |
| Interaction | CIC interactions | ZMYM2 HUWE1 RAD54L2 HNF4A TFDP1 SALL1 ZFHX4 NFIC ZFP64 ATF1 PBX3 NFAT5 | 5.46e-04 | 673 | 117 | 12 | int:CIC |
| Interaction | VSX1 interactions | 5.89e-04 | 66 | 117 | 4 | int:VSX1 | |
| Interaction | SYNC interactions | 6.24e-04 | 67 | 117 | 4 | int:SYNC | |
| Interaction | VPS50 interactions | 6.28e-04 | 118 | 117 | 5 | int:VPS50 | |
| Interaction | COP1 interactions | 6.37e-04 | 326 | 117 | 8 | int:COP1 | |
| Interaction | MAX interactions | 6.63e-04 | 251 | 117 | 7 | int:MAX | |
| Interaction | CRX interactions | 7.11e-04 | 254 | 117 | 7 | int:CRX | |
| Cytoband | 1q42.11 | 2.91e-04 | 10 | 118 | 2 | 1q42.11 | |
| Cytoband | 2q21.1 | 4.61e-04 | 58 | 118 | 3 | 2q21.1 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 4.45e-07 | 208 | 118 | 9 | M39233 | |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 8.85e-07 | 166 | 118 | 8 | M6826 | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-08 | 188 | 118 | 8 | 8671fdbc4138e6f9559920779c98628ed80f0da3 | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-08 | 190 | 118 | 8 | d3e46cf800a07ca9b01c78192962d223b9785d05 | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-08 | 190 | 118 | 8 | dd89ef1ecea20b2f6fbdc6cea4ca41b28b3ed822 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.14e-08 | 199 | 118 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-07 | 188 | 118 | 7 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-07 | 188 | 118 | 7 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | COVID-19-COVID-19_Mild-Others-HSPC|COVID-19_Mild / Disease, condition lineage and cell class | 1.04e-06 | 199 | 118 | 7 | 0230103c37ae3aff58240739b89f2c36b1e39a69 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.04e-06 | 199 | 118 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.07e-06 | 200 | 118 | 7 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.07e-06 | 200 | 118 | 7 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_systemic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.10e-06 | 141 | 118 | 6 | dcc56aef1b31bfe0de84cb0b5c77d242681cf19c | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 5.21e-06 | 165 | 118 | 6 | 7b992843bd8ef92a7a76b1d681fa84efde6f5bdd | |
| ToppCell | Healthy_Control-Myeloid-Mast|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 7.30e-06 | 175 | 118 | 6 | ca187074adcc9b8bd0fa270e2ede1564c8e6c6cf | |
| ToppCell | Healthy_Control-Myeloid-Mast-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 7.30e-06 | 175 | 118 | 6 | eadbbcdf2aef4cee268bc70a7a2c4175d898953b | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-HSC-MPP|lymph-node_spleen / Manually curated celltypes from each tissue | 7.54e-06 | 176 | 118 | 6 | de67ed15a50d2515ba6d152c1011a3367f77aedd | |
| ToppCell | COVID-19_Mild-Hematopoietic_SC-HSPC|COVID-19_Mild / Disease group, lineage and cell class | 8.31e-06 | 179 | 118 | 6 | 19fcf48f5e02e4cb2b328efb4502f337e1282f72 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.31e-06 | 179 | 118 | 6 | 4bb2debfc9e9f258cd38e797ef160bd440aad6af | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.31e-06 | 179 | 118 | 6 | 2f690f933bf6b99abeb31766e0b22bdbe36c1ba0 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.31e-06 | 179 | 118 | 6 | 3e2c937369b8190fd5d5a31689d029e6e89fb5e2 | |
| ToppCell | COVID-19_Mild-Hematopoietic_SC|COVID-19_Mild / Disease group, lineage and cell class | 8.31e-06 | 179 | 118 | 6 | 50a073166e34bcfa52a62c4dafb3aef724e0fa8e | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.85e-06 | 181 | 118 | 6 | e7f7b519c2a01c15f26df11ec9b434c0d1630c7a | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.85e-06 | 181 | 118 | 6 | 54a19cf6a3b752e2391feb8b316bebee0e602d17 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.85e-06 | 181 | 118 | 6 | 5b84625b1d3737708001b64f6da9360330d39a27 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.13e-06 | 182 | 118 | 6 | 6497eeafb2b137e70261ec0314782831892a940d | |
| ToppCell | Control-Hematopoietic_SC-HSPC|Control / Disease group, lineage and cell class | 9.13e-06 | 182 | 118 | 6 | 14e347c0e6444410f1948851407bb18c706569f4 | |
| ToppCell | Control-Hematopoietic_SC|Control / Disease group, lineage and cell class | 9.13e-06 | 182 | 118 | 6 | 43243c6bae2ac7fa3fd1f193a17f61ee4d938ea9 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.13e-06 | 182 | 118 | 6 | d0ebf2f0d5370458ab81485a0017c311077133d5 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.13e-06 | 182 | 118 | 6 | bd1626261803324084fafca2f6665b50854e7fae | |
| ToppCell | healthy_donor-Myeloid-Monocytic-SC_&_Eosinophil|healthy_donor / Disease condition, Lineage, Cell class and subclass | 9.13e-06 | 182 | 118 | 6 | 6bd6c32c48fecd6d03ac8a09e405b3b99bdc12ae | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.13e-06 | 182 | 118 | 6 | 2a6d1246bfb5899a0861c7f2f8fb9b43b0df8acc | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.13e-06 | 182 | 118 | 6 | 918286422b3eab32d962b49aa07b1b9512e51d9d | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.13e-06 | 182 | 118 | 6 | 0d9b8c900da8cbae9cde72aecd4026b1ac2bbd67 | |
| ToppCell | COVID-19_Moderate-HSPC|World / disease group, cell group and cell class | 9.72e-06 | 184 | 118 | 6 | ccc93babe1fcdeb66b78e1d8414357877a7c45bd | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.00e-05 | 185 | 118 | 6 | ef3c1fd52d21d96f81fb0e5097b24be0ce16e222 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.00e-05 | 185 | 118 | 6 | c357fa098b561da16c9fa82b0c3563b5cd3fa875 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.03e-05 | 186 | 118 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.10e-05 | 188 | 118 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 1.10e-05 | 188 | 118 | 6 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 189 | 118 | 6 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | COVID_vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.13e-05 | 189 | 118 | 6 | 2157a2d40613f7d5ce2e7dbd266df441e449cdaf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 189 | 118 | 6 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 189 | 118 | 6 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 189 | 118 | 6 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 190 | 118 | 6 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-05 | 192 | 118 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.27e-05 | 193 | 118 | 6 | 305e15ee467826ee08b2617c69f250ad39c11b19 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.27e-05 | 193 | 118 | 6 | be75abfdf5301cf33df8ee9ed92504d44fdf19a6 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.27e-05 | 193 | 118 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.27e-05 | 193 | 118 | 6 | dd376664906caccc9c2065f8e7a364509e18a5cc | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-05 | 196 | 118 | 6 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.43e-05 | 197 | 118 | 6 | b71da7f2fd8d526fb6e5d57e60fc08acdd8dbefb | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-05 | 198 | 118 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Control-Control-Others-HSPC|Control / Disease, condition lineage and cell class | 1.52e-05 | 199 | 118 | 6 | b71169be0d916b2ed139a3122d78bb154c71edb4 | |
| ToppCell | MS-Multiple_Sclerosis-Others-HSPC|Multiple_Sclerosis / Disease, condition lineage and cell class | 1.52e-05 | 199 | 118 | 6 | 7f4a22207a8b27af9a070d289e31ebd0e57af1a6 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.52e-05 | 199 | 118 | 6 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 118 | 6 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 118 | 6 | f100edfd2b3b742458cbbf34de9c403c4d272d3c | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-05 | 200 | 118 | 6 | fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 118 | 6 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary|LPS_only / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 118 | 6 | ce8281c9556a1f64f8ca8a029110077d4ef5b35e | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 118 | 6 | f15fffefe372005c33e31845982e2d2714ac26af | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 118 | 6 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 118 | 6 | fa1eaf008b54bdf7bbcdec8134460c5f64490de9 | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_only / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 118 | 6 | 83c4181c083b364f0d3a89ae7a0504781fa9fa9f | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_only / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 118 | 6 | f15baf287ec467664c23faa53fdea45257f7b9d0 | |
| ToppCell | Thalamus-Macroglia-OLIGODENDROCYTE-O2-Trf|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.92e-05 | 123 | 118 | 5 | 3b97ff4de1e16652291db1c9e2a8474675fcdbfe | |
| ToppCell | Thalamus-Macroglia-OLIGODENDROCYTE-O2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.92e-05 | 123 | 118 | 5 | fd981879529ced0e3023a1f3f8794ce8ff4d99a8 | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.51e-05 | 130 | 118 | 5 | 0a6b87635e650df431a88f2e6396abead84d901d | |
| ToppCell | BAL-Control-cDC_6|Control / Compartment, Disease Groups and Clusters | 8.51e-05 | 168 | 118 | 5 | 65ec473cff748b334c0a66e33bc34a8465fe7631 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D175|Adult / Lineage, Cell type, age group and donor | 8.51e-05 | 168 | 118 | 5 | 14071b961c9bdb54a8259b12a88237b802cbde36 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 9.51e-05 | 172 | 118 | 5 | da959c1abadafd79b7a0088a25eb8ef8efa3a0c2 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.51e-05 | 172 | 118 | 5 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.77e-05 | 173 | 118 | 5 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | COVID-19_Mild-Neu_3|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 1.06e-04 | 176 | 118 | 5 | 2049767fd591045cfcf5b1071d80798e52843f27 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 177 | 118 | 5 | 4943d040eee0f9dceaddc7498171281d170e271f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 177 | 118 | 5 | 3f2272b577c862dba8ccfb41184054bbd0ace6f5 | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Definitive_erythroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.24e-04 | 182 | 118 | 5 | 0c77ef4556c1d1512ebe9077df858b28f9e38dd5 | |
| ToppCell | droplet-Fat-Scat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 182 | 118 | 5 | fea094fe0e7796c084e60b5310c1559658633f7a | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.27e-04 | 183 | 118 | 5 | 8820cfed27b292bc0bc9cde4005219ed41900552 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 1.27e-04 | 183 | 118 | 5 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | LV-07._Pericyte|World / Chamber and Cluster_Paper | 1.27e-04 | 183 | 118 | 5 | 273db6a3b00a93ca852498471187b642b5368185 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 185 | 118 | 5 | ca69499ba8c39b7ed6717d05685d6f70066a77bd | |
| ToppCell | COVID-19_Moderate-HSPC|COVID-19_Moderate / disease group, cell group and cell class | 1.34e-04 | 185 | 118 | 5 | cacc6ab5f26f6c803894567fb838ea06eaa7efe5 | |
| ToppCell | facs-SCAT-Fat-24m-Endothelial-endothelial_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 187 | 118 | 5 | 43e35ec995afd8780893de42ac4ee466794991d7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.41e-04 | 187 | 118 | 5 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | facs-SCAT-Fat-24m-Endothelial|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 187 | 118 | 5 | 8ca9481d661626f6f0e1b61eb142b051192a9208 | |
| ToppCell | RV-07._Pericyte|World / Chamber and Cluster_Paper | 1.41e-04 | 187 | 118 | 5 | dc274d6bbda619a2c914d84e2b4069cfef1739d1 | |
| ToppCell | facs-SCAT-Fat-24m-Endothelial-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 187 | 118 | 5 | 51336037dfd4bbe9fe9ce1e5b6b92d037156690c | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 188 | 118 | 5 | e901a9bdf00b8e91806f445af66647373bf62661 | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.44e-04 | 188 | 118 | 5 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 188 | 118 | 5 | 5cf060bb8adaefa9964187195d67993c1248ef47 | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-progenitor_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.44e-04 | 188 | 118 | 5 | c613c6c7b6de8ed514253c9f9b8622c56fcc1452 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.44e-04 | 188 | 118 | 5 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 188 | 118 | 5 | 449f9602df3c83b2110eb479a00d428d1b55b423 | |
| ToppCell | wk_08-11-Epithelial-PNS-intermediate_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.44e-04 | 188 | 118 | 5 | 3f3a744b2615bf72f6119f26087099110c0d21fc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 189 | 118 | 5 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.48e-04 | 189 | 118 | 5 | d05e043d0874b8563b9f5514f6c884b35c603e3a | |
| ToppCell | Healthy-HSPC|Healthy / disease group, cell group and cell class | 1.48e-04 | 189 | 118 | 5 | 214b225effc40ca1b83dd8052f2a7b80b65d4938 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.52e-04 | 190 | 118 | 5 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 190 | 118 | 5 | c8370c922e0cf0e0c36e02e1ed2b4053ad6a8073 | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; HL60; HT_HG-U133A | 8.50e-08 | 198 | 118 | 10 | 2362_DN | |
| Drug | 3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; MCF7; HT_HG-U133A | USP34 CDC42BPA ARHGEF12 ARHGAP35 ARHGEF17 PHLDB1 SCAPER MMP9 | 7.33e-06 | 192 | 118 | 8 | 3382_DN |
| Drug | Flumethasone [2135-17-3]; Down 200; 9.8uM; PC3; HT_HG-U133A | 7.90e-06 | 194 | 118 | 8 | 4272_DN | |
| Drug | Sulfadoxine [2447-57-6]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 8.52e-06 | 196 | 118 | 8 | 3547_DN | |
| Drug | Clomipramine hydrochloride [17321-77-6]; Up 200; 11.4uM; HL60; HG-U133A | 8.52e-06 | 196 | 118 | 8 | 1566_UP | |
| Drug | Noscapine [128-62-1]; Down 200; 9.6uM; PC3; HT_HG-U133A | 8.84e-06 | 197 | 118 | 8 | 5851_DN | |
| Drug | Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; PC3; HT_HG-U133A | 8.84e-06 | 197 | 118 | 8 | 4077_UP | |
| Drug | Vitexin [3681-93-4]; Up 200; 9.2uM; HL60; HT_HG-U133A | 9.18e-06 | 198 | 118 | 8 | 2155_UP | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 1uM; PC3; HT_HG-U133A | 9.52e-06 | 199 | 118 | 8 | 4334_UP | |
| Drug | S-2-pentyl-4-pentynoic hydroxamic acid | CDK16 ZNF407 SALL4 ARHGEF17 SLC4A2 FOXD3 PHLDB1 SALL1 NFIC FBXO28 ZFP64 SMARCE1 ATF1 GOLGA5 MAP3K7 | 2.73e-05 | 834 | 118 | 15 | ctd:C513635 |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 5.15e-05 | 185 | 118 | 7 | 1673_DN | |
| Drug | Phenacetin [62-44-2]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 5.90e-05 | 189 | 118 | 7 | 2832_UP | |
| Drug | Imipenem [74431-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 6.51e-05 | 192 | 118 | 7 | 2873_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 6.95e-05 | 194 | 118 | 7 | 1060_UP | |
| Drug | Mefloquine hydrochloride [51773-92-3]; Up 200; 9.6uM; HL60; HG-U133A | 6.95e-05 | 194 | 118 | 7 | 1364_UP | |
| Drug | Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | 6.95e-05 | 194 | 118 | 7 | 3758_DN | |
| Drug | Acyclovir [59277-89-3]; Up 200; 17.8uM; PC3; HG-U133A | 7.18e-05 | 195 | 118 | 7 | 1960_UP | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 7.18e-05 | 195 | 118 | 7 | 1532_DN | |
| Drug | Gramine [87-52-5]; Up 200; 23uM; PC3; HT_HG-U133A | 7.41e-05 | 196 | 118 | 7 | 3999_UP | |
| Drug | rosiglitazone; Down 200; 10uM; HL60; HT_HG-U133A | 7.41e-05 | 196 | 118 | 7 | 1174_DN | |
| Drug | Hyoscyamine (L) [101-31-5]; Down 200; 13.8uM; PC3; HT_HG-U133A | 7.41e-05 | 196 | 118 | 7 | 2108_DN | |
| Drug | Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 7.41e-05 | 196 | 118 | 7 | 3416_UP | |
| Drug | 5253409; Down 200; 17uM; MCF7; HT_HG-U133A_EA | 7.41e-05 | 196 | 118 | 7 | 844_DN | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 7.41e-05 | 196 | 118 | 7 | 2225_DN | |
| Drug | Adrenosterone [382-45-6]; Up 200; 13.4uM; PC3; HT_HG-U133A | 7.65e-05 | 197 | 118 | 7 | 5045_UP | |
| Drug | Naloxone hydrochloride [357-08-4]; Up 200; 11uM; MCF7; HT_HG-U133A | 7.65e-05 | 197 | 118 | 7 | 1506_UP | |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.65e-05 | 197 | 118 | 7 | 6935_DN | |
| Drug | Cefotetan [69712-56-7]; Up 200; 7uM; PC3; HT_HG-U133A | 7.90e-05 | 198 | 118 | 7 | 3997_UP | |
| Drug | Bromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 7.90e-05 | 198 | 118 | 7 | 1507_UP | |
| Drug | Progesterone [57-83-0]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 8.15e-05 | 199 | 118 | 7 | 3287_UP | |
| Drug | Dioxybenzone [131-53-3]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 8.15e-05 | 199 | 118 | 7 | 6478_UP | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 8.15e-05 | 199 | 118 | 7 | 6963_DN | |
| Disease | Malignant neoplasm of breast | EVL SMARCAL1 POU2F1 WNK1 RFX2 NCOR1 FOXP4 HEY1 GLI1 ZFP64 BOD1L1 LRBA MMP9 PRRC2A MED12 | 1.53e-05 | 1074 | 113 | 15 | C0006142 |
| Disease | glaucoma (is_marker_for) | 5.94e-05 | 20 | 113 | 3 | DOID:1686 (is_marker_for) | |
| Disease | Antihypertensive use measurement | 7.48e-05 | 265 | 113 | 7 | EFO_0009927 | |
| Disease | vital capacity | USP34 RBBP8 ZBTB4 CYB5B NCOR1 ACAN CROCC2 CAPRIN2 ATXN3 SLX4IP LRBA NEURL1B NFAT5 TNXB AGAP1 | 7.61e-05 | 1236 | 113 | 15 | EFO_0004312 |
| Disease | pulse pressure measurement | USP34 MXRA5 DEPTOR ARHGEF12 CCDC6 NEK9 PHC2 MSI2 ZFHX4 SLX4IP IQCJ-SCHIP1 NEURL1B MBD5 PBX3 NFAT5 CDH17 | 8.15e-05 | 1392 | 113 | 16 | EFO_0005763 |
| Disease | intracranial aneurysm (implicated_via_orthology) | 8.68e-05 | 4 | 113 | 2 | DOID:10941 (implicated_via_orthology) | |
| Disease | Sjogren's syndrome (is_marker_for) | 1.04e-04 | 24 | 113 | 3 | DOID:12894 (is_marker_for) | |
| Disease | eosinophil count | SCHIP1 RBBP8 WNK1 PHC2 MSI2 IFIH1 SALL1 MDN1 SLC45A3 NFIC SMARCE1 IQCJ-SCHIP1 NEURL1B MBD5 TNXB ZNF292 | 1.76e-04 | 1488 | 113 | 16 | EFO_0004842 |
| Disease | Glioblastoma | 2.46e-04 | 79 | 113 | 4 | C0017636 | |
| Disease | arteriosclerosis (implicated_via_orthology) | 3.01e-04 | 7 | 113 | 2 | DOID:2349 (implicated_via_orthology) | |
| Disease | blood urea nitrogen measurement | 3.59e-04 | 452 | 113 | 8 | EFO_0004741 | |
| Disease | cholelithiasis | 3.71e-04 | 88 | 113 | 4 | EFO_0004799 | |
| Disease | pseudohypoaldosteronism (is_implicated_in) | 4.01e-04 | 8 | 113 | 2 | DOID:4479 (is_implicated_in) | |
| Disease | Prostatic Neoplasms | 6.19e-04 | 616 | 113 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 6.19e-04 | 616 | 113 | 9 | C0376358 | |
| Disease | Pseudohypoaldosteronism, Type I | 6.41e-04 | 10 | 113 | 2 | C0268436 | |
| Disease | Pseudohypoaldosteronism | 6.41e-04 | 10 | 113 | 2 | C0033805 | |
| Disease | Hyperpotassemia and Hypertension, Familial | 6.41e-04 | 10 | 113 | 2 | C2713447 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Recessive | 6.41e-04 | 10 | 113 | 2 | C1449843 | |
| Disease | Pseudohypoaldosteronism, Type II | 6.41e-04 | 10 | 113 | 2 | C1449844 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Dominant | 6.41e-04 | 10 | 113 | 2 | C1449842 | |
| Disease | gallstones | 8.04e-04 | 108 | 113 | 4 | EFO_0004210 | |
| Disease | multiple sclerosis (is_marker_for) | 8.86e-04 | 49 | 113 | 3 | DOID:2377 (is_marker_for) | |
| Disease | forced expiratory volume | TSHZ3 RBBP8 ARHGEF17 CYB5B NCOR1 ACAN CROCC2 ATXN3 NFAT5 TNXB | 9.22e-04 | 789 | 113 | 10 | EFO_0004314 |
| Disease | phosphatidylcholine 34:4 measurement | 9.36e-04 | 12 | 113 | 2 | EFO_0010378 | |
| Disease | sex interaction measurement, inflammatory bowel disease | 1.24e-03 | 55 | 113 | 3 | EFO_0003767, EFO_0008343 | |
| Disease | ventricular septal defect (is_implicated_in) | 1.28e-03 | 14 | 113 | 2 | DOID:1657 (is_implicated_in) | |
| Disease | hepatoblastoma (is_marker_for) | 1.48e-03 | 15 | 113 | 2 | DOID:687 (is_marker_for) | |
| Disease | anemia (implicated_via_orthology) | 1.48e-03 | 15 | 113 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (is_implicated_in) | 1.68e-03 | 16 | 113 | 2 | DOID:0060041 (is_implicated_in) | |
| Disease | ocular hypertension (biomarker_via_orthology) | 1.90e-03 | 17 | 113 | 2 | DOID:9282 (biomarker_via_orthology) | |
| Disease | Limb Deformities, Congenital | 1.90e-03 | 17 | 113 | 2 | C0206762 | |
| Disease | hypertrophic cardiomyopathy (is_marker_for) | 1.90e-03 | 17 | 113 | 2 | DOID:11984 (is_marker_for) | |
| Disease | monocyte percentage of leukocytes | 2.03e-03 | 731 | 113 | 9 | EFO_0007989 | |
| Disease | late-onset myasthenia gravis | 2.14e-03 | 18 | 113 | 2 | EFO_1001490 | |
| Disease | Adrenocortical carcinoma | 2.14e-03 | 18 | 113 | 2 | C0206686 | |
| Disease | cataract | 2.15e-03 | 141 | 113 | 4 | MONDO_0005129 | |
| Disease | urate measurement | 2.34e-03 | 895 | 113 | 10 | EFO_0004531 | |
| Disease | diet measurement, HOMA-B | 2.38e-03 | 19 | 113 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | Cholecystitis | 2.38e-03 | 19 | 113 | 2 | HP_0001082 | |
| Disease | Nonorganic psychosis | 2.38e-03 | 69 | 113 | 3 | C0349204 | |
| Disease | uric acid measurement | 2.44e-03 | 610 | 113 | 8 | EFO_0004761 | |
| Disease | neutrophil count | SEMA6C DENND4A CDC42BPA RBBP8 ARHGEF12 POU2F1 HNF4A MSI2 IFIH1 SALL1 LRBA TNXB ZNF292 | 2.45e-03 | 1382 | 113 | 13 | EFO_0004833 |
| Disease | dentures | 2.48e-03 | 70 | 113 | 3 | EFO_0010078 | |
| Disease | dental caries, dentures | 2.48e-03 | 70 | 113 | 3 | EFO_0003819, EFO_0010078 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.82e-03 | 152 | 113 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | atopic eczema | 2.90e-03 | 252 | 113 | 5 | EFO_0000274 | |
| Disease | Disproportionate short stature | 3.26e-03 | 77 | 113 | 3 | C0878659 | |
| Disease | sexual dimorphism measurement | CDC42BPA RBBP8 ZBTB4 RAD54L2 HNF4A ZNF608 NFIC ACAN ATXN3 ATF1 MMP9 | 3.49e-03 | 1106 | 113 | 11 | EFO_0021796 |
| Disease | Renal glomerular disease | 3.49e-03 | 23 | 113 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 3.49e-03 | 23 | 113 | 2 | C4521256 | |
| Disease | squamous cell lung carcinoma | 3.78e-03 | 165 | 113 | 4 | EFO_0000708 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SEGSLGNSRSSTQMN | 136 | Q99569 | |
| DSMSGAGRATAATGQ | 96 | Q8N944 | |
| SASNSSEVDGGENMT | 856 | P04920 | |
| SGNVTSASGSQMASG | 441 | Q9UPQ3 | |
| TNGTGGSSGMEVDAA | 11 | Q7L5N1 | |
| MNISGSSCGSPNSAD | 1 | Q99708 | |
| SSSEGLGAQMDHAGT | 396 | Q8N9M1 | |
| TDGGDGTMATAAAAA | 526 | Q9NQ94 | |
| GSESKEMTQTGSGSA | 1456 | Q8N7X0 | |
| SGSDSSQSMNGLEVA | 21 | Q13304 | |
| QESSFGSPTGNQMSS | 281 | Q5M775 | |
| TAEDSAQMQNGGPST | 136 | Q6AI12 | |
| MADSASESDTDGAGG | 1 | Q16204 | |
| DGAGGNSSSSAAMQS | 11 | Q16204 | |
| GEDSTLASSMGEATN | 666 | Q9Y4B4 | |
| SQAGENSLFMGSTPS | 1311 | Q9Y4B4 | |
| SENGDMNSSVGSSDG | 366 | Q9UI36 | |
| ASLDSGEGPSGMASQ | 411 | Q9UER7 | |
| MSSVASGASFSQEGG | 666 | Q9NZN5 | |
| SNNSAGKISGESMES | 971 | Q7Z401 | |
| MEANGSQGTSGSAND | 1 | Q96DH6 | |
| DGLNLSSMNSAGVSG | 311 | Q96PE2 | |
| GDQASSGVEVESSMG | 226 | Q9NZ53 | |
| TRADSTVMGGNSAGE | 331 | P14780 | |
| ENGSDTSSKSLSMGN | 1876 | Q8WXI7 | |
| SGSSGSFNLPNSGDM | 336 | P40426 | |
| TSDSQGGNQMLDEGF | 4486 | Q9NU22 | |
| MANSTGLNASEVAGS | 1 | Q9BZJ7 | |
| LRSFMSDSGSSVNGG | 161 | P08235 | |
| EAMGNSNGASSSCPG | 796 | Q8TD19 | |
| GSSSNGSSINMSGID | 631 | Q8TBA6 | |
| GSSINMSGIDNGEGT | 636 | Q8TBA6 | |
| TSSGALGSDLGDAMS | 321 | P54252 | |
| VGSGDLFSGMNSVSS | 41 | Q9NRR3 | |
| MGNDTSPSEGTNLNA | 36 | P41235 | |
| SAGMTGTSAQSAGVA | 2821 | Q7Z5P9 | |
| PAGGAQGSSHDESSM | 206 | Q9UI08 | |
| MGSRNSSSAGSGSGD | 1 | Q8TEB1 | |
| NGSLSSSPEEMSGAE | 16 | Q5TAQ9 | |
| DEGQSNSATSTGSFM | 306 | O43318 | |
| GTNSSRESNGTMADL | 836 | Q96J66 | |
| SSESDFSDAEGGMQS | 396 | Q6AI08 | |
| DSAQASDMGGESPGS | 1756 | P50851 | |
| SDMGGESPGSRSSNA | 1761 | P50851 | |
| NGTLAADMSSISQGS | 1591 | Q93074 | |
| GSAANTDSGVEMTGN | 456 | P08151 | |
| TDSGVEMTGNAGGST | 461 | P08151 | |
| EMTGNAGGSTEDLSS | 466 | P08151 | |
| KMSDNASASSGSDQG | 526 | Q96RT8 | |
| VTTGADSNGEMSPAE | 46 | Q8IVH2 | |
| DGEQDGAAGSMDAST | 991 | Q7Z6Z7 | |
| SQSDGSCTQAGGGME | 206 | Q9UPP2 | |
| MFQTSSSGDGEETGT | 981 | O94916 | |
| GESSVAMGTSGEASG | 2016 | P16112 | |
| SMESGDGNTGTQTNG | 11 | P14859 | |
| EGPMTSAASDQSDSQ | 1976 | Q8NFC6 | |
| MGSDGESDQASATSS | 76 | Q00536 | |
| MSSASSEPGNGDASQ | 1 | H7BZ55 | |
| MSGSMATAEASGSDG | 1 | O43169 | |
| MEEGGSTGSAGSDSS | 1 | Q8TB45 | |
| EVMESAVGNSSGSGQ | 326 | Q9NVF7 | |
| DESLGHNSNMGSDSG | 271 | Q9BYX4 | |
| GSDSGTMGSDSDEEN | 281 | Q9BYX4 | |
| AGAAAAAASGMESNT | 31 | Q9NS18 | |
| MPVATSDQEGDSSFG | 206 | P56746 | |
| TFNSGDSGQGDSRSM | 956 | Q6IMN6 | |
| AGEGDMSSINNTLSN | 946 | Q9P267 | |
| ADENGNLSSALGSMS | 26 | Q9Y5J3 | |
| MSGNGNAAATAEENS | 1 | P08397 | |
| SRGSNSGMDSNIDLT | 361 | O95810 | |
| MGGQSENSFSDTTSV | 216 | Q12864 | |
| TDNDSDFSASMGSGS | 466 | Q9BY12 | |
| DSSSVGGDMESQSAG | 901 | Q9NSC2 | |
| GGDMESQSAGSPAIS | 906 | Q9NSC2 | |
| SDGLTNDSSSLMGDQ | 756 | Q9UJQ4 | |
| MMSQSSGSGDGNDDE | 1 | Q13620 | |
| GGSASDMSGQTVLTA | 6 | Q9UJU5 | |
| MSDEEARQSGGSSQA | 1 | O00233 | |
| GASAAPEEGMSSDSD | 891 | O94972 | |
| MATASGASDLSGSGA | 1 | Q3MII6 | |
| SMAEEGTSDSNTGSE | 376 | Q969G3 | |
| GTSDATGSLQGDSMT | 621 | O15061 | |
| MQNSEGGADSPASVA | 1 | P48378 | |
| DGMDLGSDAGSSSSS | 26 | P0DPB3 | |
| LNSSGGGDSDMAAAQ | 2216 | O75376 | |
| MSADGAEADGSTQVT | 1 | O60664 | |
| ASGTSGSSSQNMGDT | 911 | Q9NZC9 | |
| GSSSQNMGDTLDESS | 916 | Q9NZC9 | |
| MSQSDSGVDLSGDSQ | 1646 | P48634 | |
| AGPSSSQISGGAMDS | 1841 | P48634 | |
| SNVGTSGDQDDSTMK | 41 | P0CG39 | |
| STISAGSAAEGSMGD | 1321 | Q9P2F8 | |
| GQDAGMASGRTEAQS | 141 | Q9NSC7 | |
| SNVGTSGDQDDSTMK | 41 | P0CG38 | |
| QTISGDSGGMSAVSD | 926 | Q15714 | |
| EDGMDLGSDAGSSSS | 101 | B3KU38 | |
| QSGSPRTGMGSDQED | 191 | P08651 | |
| SEGSLSSGGMDQGSD | 1666 | Q5VT25 | |
| QSNGSGNGSDSEMDT | 1126 | Q9NRY4 | |
| GDTGGASSEDSLMTS | 416 | Q96JT2 | |
| NDGQASSSPPSESMG | 206 | Q5VYV7 | |
| NDQGSSSPSNDEAAM | 586 | O00327 | |
| GDGENSGVSAAVTSM | 81 | P18846 | |
| SGAGSEDMGTTVNGD | 61 | P09497 | |
| GSPSEDGMQSARTQA | 56 | Q13610 | |
| NEDTASASEGSNMIG | 351 | Q96JG6 | |
| ASDLTNGADGMLATS | 361 | Q14186 | |
| NEQTSEPSNMDGNSG | 326 | P32780 | |
| MTSGNGNSASSIAGT | 536 | Q8IXK0 | |
| GDEGNTEMESTTGSS | 2771 | Q86UP3 | |
| AAMDSDVSDGSGQSK | 356 | Q96MW7 | |
| GANSSTLNGSAAMLD | 156 | Q9H2B4 | |
| SAEGSASGGGMQAAA | 321 | Q5TF21 | |
| GEEMQNGAGASRTST | 4031 | P22105 | |
| GSLSGSQDDSDSDMT | 446 | A8MQ27 | |
| ETSMNGLSGGVGANS | 491 | O60281 | |
| EMQVSSSSGEAGGGS | 821 | Q9P1Z0 | |
| TGPGSGASSQDSSMD | 71 | Q9BY07 | |
| SGGTDVDQAGNQESM | 551 | Q9H3T2 | |
| TGGNSACSPDNMSSA | 1126 | Q86UU1 | |
| MEASSDGGFRSQENS | 656 | Q63HK5 | |
| NAGMGNSGITTEPDS | 166 | Q9UBW7 | |
| ATGMNSALGQSVSSG | 146 | Q9ULD9 | |
| MSEEEQGSGTTTGCG | 1 | Q15633 | |
| NSMGKRGFSESSNSD | 46 | Q9C0G0 | |
| MQGSSDETANSGEDG | 561 | Q70CQ2 | |
| GDSQGMSERNGTSSG | 656 | Q70CQ2 | |
| ASGMSDGNENVPSSS | 1076 | Q9H4A3 | |
| MNASSEGESFAGSVQ | 1 | Q9NTW7 | |
| MEGAGENAPESSSSA | 1 | Q9BYX2 | |
| DGSLVNSFMQSDDSG | 2281 | Q9NR99 |